Anvar ParaparambilVellamgot

Dr. Anvar ParaparambilVellamgot

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2023 in BMJ Open Quality
Verified
Journal Article
Open access
PDF file
APAnvar ParaparambilVellamgot
Anvar ParaparambilVellamgot
KSKhalil Salameh
Khalil Salameh
RARajai Rofail AlBedaywi
Rajai Rofail AlBedaywi
SASamer Mahmoud Alhoyed
Samer Mahmoud Alhoyed
LHLina Hossain Habboub
Lina Hossain Habboub
AZAlmunzer Zakaria
Almunzer Zakaria
Being an important cause of early-onset neonatal sepsis, clinical chorioamnionitis in the mother results in frequent laboratory workup and antibiotic use for the neonate. Neonatal intensive care units (NICUs) in Qatar follow the categorical approach recommended by the Centers for Disease Control and Prevention, USA, and all chorioamnionitis-exposed neonates receive antibiotics. Our project aimed to reduce antibiotic use among chorioamnionitis-exposed, asymptomatic term babies by adopting the early-onset sepsis calculator (EOSCAL). Reduction of blood culture and NICU stay duration were added as secondary objectives later. The Institute of Healthcare Improvement Model of Improvement was used. Antibiotic use rate was the primary outcome measure. Blood culture rate and early transfer to the postnatal ward were added after 1 year. The process measures included the EOSCAL use rate and calculation error rate. The rate of positive culture among untreated babies within the first week was taken as a balancing measure. Monthly data were collected from February 2020 and entered as run charts. Calculation errors were dealt by multiple PDSAs. Additional outcome measures were added in January 2021. Data collection and monitoring continued till December 2022. Among 3837 inborn NICU admissions, 464 (12 %) were chorioamnionitis-exposed babies. Of them, 341 (74%) cases were eligible for inclusion. Among eligible cases, 270 (79%) did not receive antibiotics. Blood culture could be avoided among 106 (97% of low-risk babies) and NICU stay was reduced among 45 (92% of eligible low-risk babies). None of the untreated babies developed sepsis during the first week. Implementation of this project effectively and safely reduced the antibiotic use and blood culture rate among term, well-appearing babies exposed to chorioamnionitis. The project resulted in enhanced patient safety, experience and flow and reduced cost. It is recommendable to other NICU settings in Qatar.

27 June 2025 in BMJ Paediatrics Open
Verified
Journal Article
Open access
PDF file
APAnvar ParaparambilVellamgot
Anvar ParaparambilVellamgot
SSSajid Thyvilayil Salim
Sajid Thyvilayil Salim
KSKhalil Salameh
Khalil Salameh
RVRajesh Pattu Valappil
Rajesh Pattu Valappil
STSudheer Babu Kurunthattil Thazhe
Sudheer Babu Kurunthattil Thazhe
AEAbdurahiman Elikkottil
Abdurahiman Elikkottil
Background: Early-onset neonatal sepsis (EOS) is an important cause of neonatal morbidity and mortality. The incidence has declined due to intrapartum antibiotic use and improved perinatal care. This study aimed to analyse EOS incidence, pathogen profiles, resistance patterns and neonatal outcomes in Qatar. Objectives: The primary objective was to estimate the incidence and trend of EOS among neonates born in Qatar from July 2015 to December 2022. Secondary objectives included describing risk factors, clinical characteristics and outcomes associated with EOS. Methodology: The study reviewed medical records in three major public hospitals in Qatar to identify EOS cases among live-born infants. Results: The study analysed 179 147 live births (LBs) and identified 157 cases of EOS, with an overall EOS incidence of 0.88 per 1000 LBs. Group B Streptococcus was the most common pathogen (58.6%), followed by Escherichia coli (15.3%). A significant decline in EOS incidence was observed from 2015 to 2022. The overall mortality rate was 13.4%, with the significant predictors being decreasing gestational age, chorioamnionitis and thrombocytopenia. The combined outcome of death and neurodisability was observed in 21% of the cohort. Conclusion: This study highlights an EOS incidence of 0.88 per 1000 LB in Qatar, a rate comparable to high-income countries. The decline in incidence underscores the effectiveness of improved prenatal care and screening. Continued surveillance and enhanced preventive measures are essential to further reduce incidence and improve outcomes for vulnerable newborns.

19 December 2024 in Case Reports in Dermatology
Verified
Journal Article
Open access
APAnvar ParaparambilVellamgot
Anvar ParaparambilVellamgot
RVRajesh Pattu Valappil
Rajesh Pattu Valappil
ATAhmed Hosny Tomerak
Ahmed Hosny Tomerak
HKHakam Khatib
Hakam Khatib
KSKhalil Salameh
Khalil Salameh
Introduction: Aplasia cutis congenita (ACC) is a rare congenital disorder characterized by the localized absence of skin at birth, primarily affecting the scalp but also affecting the trunk and limbs. Nine different presentations have been reported. Group V-ACC (G-V ACC) is a rare type associated with fetus papyraceus. The pathogenesis is speculated to involve ischemia from acute hypovolemia or disseminated intravascular coagulation due to thrombotic tissue affecting the surviving twin. Management of ACC depends on lesion severity, focusing on preventing infection and promoting healing, with conservative measures in most cases and surgical intervention in some cases. The long-term prognosis for isolated G-V ACC is generally favorable unless associated with systemic complications. Case Presentation: We report a neonate diagnosed with Group G-V ACC associated with fetus papyraceus from a dichorionic diamniotic twin pregnancy. Born to a 28-year-old Asian mother, this female infant presented with extensive, healed, scar-like lesions on her flanks and upper thighs. These lesions were consistent with the “H”-shaped distribution commonly described in ACC linked to fetus papyraceus. Despite significant dermatological manifestations, the infant showed no other external abnormalities or systemic involvement, and comprehensive screenings, including ultrasounds and chromosomal microarray, were normal. Conclusion: This discussion highlights the rarity of ACC associated with fetus papyraceus, with only a few over 100 cases reported globally. This case underscores the importance of recognizing the patterns and potential complications of ACC in twins, contributing to better diagnostic acumen and management strategies for neonatal care.

12 September 2025 in Antibiotics
Verified
Journal Article
Open access
PDF file
RMRowan Mesilhy
Rowan Mesilhy
ISIbrahim Safra
Ibrahim Safra
SAShaikha Alnaimi
Shaikha Alnaimi
AAAlaa Awadullah Mohammed Ali
Alaa Awadullah Mohammed Ali
RTRayan Terkawi
Rayan Terkawi
AGAshraf Gad
Ashraf Gad
Background: Early-onset neonatal meningitis (EONM) is a rare but serious condition where antibiotics are often given for extended periods, even without a positive cerebrospinal fluid (CSF) culture. The reasons for this prolonged treatment are unknown. Methodology: This study, conducted at the Women’s Wellness and Research Center, Doha, retrospectively analyzed the determinants of prolonged antibiotic therapy among neonates with sterile CSF cultures during the first week of life, born during 2015 to 2018. Results: Of 315 neonates without confirmed meningitis, 96 (30.5%) received prolonged antibiotic therapy. These infants had significantly lower birth weights (2790 g vs. 3170 g) and gestational ages (36.7 weeks vs. 38.5 weeks). They were more likely to require respiratory support, appear ill, and have laboratory abnormalities, including neutropenia, positive blood cultures (36.5% vs. 0.9%), elevated C-reactive protein (CRP), and higher CSF protein. Multivariable analysis identified low Apgar scores (Adjusted Odds Ratio (aOR), 2.82), positive blood cultures (aOR, 118.48), traumatic lumbar puncture (LP) (aOR, 2.14), CRP levels ≥ 50 mg/L (aOR, 2.60), delayed LP (OR, 8.28), and elevated cerebrospinal fluid white cell counts (aOR, 5.47) as independent predictors of prolonged antibiotic use. Conclusions: Prolonged antibiotic use in neonates with sterile CSF cultures and suspected EONS is common and may be driven by certain clinical and laboratory indicators of illness severity and inflammation. Identifying these predictors can support risk-stratified treatment decisions, promoting safer antimicrobial stewardship.

23 November 2022 in Case Reports in Infectious Diseases
Verified
Journal Article
Open access
PDF file
SASufia Athar
Sufia Athar
APAnvar ParaparambilVellamgot
Anvar ParaparambilVellamgot
LALolwa Mohammed Alansari
Lolwa Mohammed Alansari
Introduction. Infections caused by multidrug-resistant organisms are on the rise in obstetric patients. Chorioamnionitis is associated with adverse pregnancy outcomes. If caused by multidrug-resistant organisms, chorioamnionitis is associated with high maternal and fetal morbidity. Due to the paucity of the literature and the challenges associated with their diagnosis, the diagnosis is usually delayed. This often leads to delays in management, and hence, adverse maternal and neonatal outcomes are noted. Important Clinical Findings. The patient presented with prelabour rupture of membranes for three days. She developed chorioamnionitis in labour, which was refractory to broad spectrum antibiotics. Persistent tachycardia with variable decelerations followed by prolonged fetal deceleration was observed in cardiotocography. Delivery of baby was done by cesarean section in the view of pathological findings in cardiotocography. The primary diagnoses, interventions, and outcomes. Based on the placental culture results, Amp-C Klebsiella-induced chorioamnionitis was diagnosed. Ertapenem was commenced after the sensitivity results. Good feto-maternal outcomes were observed. The neonate was admitted to the neonatal intensive care unit and discharged home in stable condition. Conclusions. Cases of multidrug-resistant organisms-induced chorioamnionitis are rarely reported, though they are associated with maternal morbidity and poor neonatal outcome. In cases of chorioamnionitis, caution should be taken in cases that are refractory to broad-spectrum antibiotics, and multidrug-resistant organisms should be suspected and managed to improve pregnancy outcome.

21 November 2025 in Frontiers in Pediatrics
Verified
Journal Article
Open access
APAnvar ParaparambilVellamgot
Anvar ParaparambilVellamgot
SSSajid Thyvilayil Salim
Sajid Thyvilayil Salim
KSKhalil Salameh
Khalil Salameh
SKSudheer Babu Kurunthattilthazhe
Sudheer Babu Kurunthattilthazhe
AEAbdurahiman Elikkottil
Abdurahiman Elikkottil
BJBiny Elizabeth Joseph
Biny Elizabeth Joseph
Introduction: Early-onset neonatal sepsis is a significant cause of neonatal morbidity and mortality worldwide. Although sepsis rates are declining, neonatal antibiotic use remains high. The early-onset sepsis risk calculator, endorsed by the American Academy of Pediatrics, is one of three evidence-based methods for identifying at-risk babies. This study retrospectively compared the calculator to the existing categorical approach. Objectives: The primary objective was to compare the effectiveness of the calculator with the existing categorical approach in identifying sepsis cases within the first 12 h of life. Secondary aims included describing the calculator's recommendations and identifying predictors of missed cases. Methods: We retrospectively analyzed cases of early-onset sepsis in late-preterm and term infants born in Qatar between 2015 and 2022. We compared the calculator's predicted effectiveness to the current categorical approach. Results: Among 179,147 live births, 157 cases were identified (0.88 per 1,000). Of 105 cases (≥34 weeks), the calculator recommended antibiotics at birth in 37.1% (95% CI: 27.8%–46.4%) compared to 52% (42.9%–62.0%) by the categorical approach ( p < 0.01), missing 16 cases. By 12 h, it identified 58.1% vs. 72.5% by the categorical approach ( p < 0.01), missing 15 cases. Overall, the calculator missed six more cases than the categorical approach. Conclusions: The calculator identified fewer cases and delayed treatment in some neonates compared to current practice. It should be used cautiously, tailored to local risks and clinical context, with close postnatal monitoring. Additional local prospective studies are necessary to improve EOS management and reduce unnecessary antibiotic use.